Which of the following is evidence against the idea that antidepressant drugs relieve depression simply by elevating neurotransmitter levels? a. The dose of drug necessary for relieving depression is greater than the amount necessary to elevate neurotransmitter levels. b. The drugs quickly affect levels of serotonin and other neurotransmitters but take weeks to alter mood. c. The drugs become less and less effective in relieving depression after weeks of use. d. Several procedures other than antidepressant drugs are also effective in relieving depression.

Which of the following is evidence against the idea that antidepressant drugs relieve depression simply by elevating neurotransmitter levels? a. The dose of drug necessary for relieving depression is greater than the amount necessary to elevate neurotransmitter levels. b. The drugs quickly affect levels of serotonin and other neurotransmitters but take weeks to alter mood. c. The drugs become less and less effective in relieving depression after weeks of use. d. Several procedures other than antidepressant drugs are also effective in relieving depression.

Essentials of Pharmacology for Health Professions

7th Edition

ISBN:9781305441620

Author:WOODROW

Publisher:WOODROW

Chapter27: Drugs And Older Adults

Section: Chapter Questions

Problem 5CRQ

See similar textbooks

Similar questions

Researchers have discovered several neurological issues in the brains of patients with affective (mood) disorders. Which of the following neurological anomalies is found in bipolar patients during a manic episode, but NOT in patients experiencing depression? A) Reduced brain tissue in prefrontal areas and hippocampus. B) Increased metabolic activity in part of the prefrontal cortex. C) Enlargement of the amygdala and hypothalamus, leading to greater stress responses and higher cortisol levels. D) Reductions in overall brain activity, and especially in prefrontal regions and other circuits that regulate emotions.
What do you think are its potential benefits of optogenetics to treat bipolar disorder? What concerns do you have about its use in treating bipolar disorder? On the whole, do you think the benefits outweigh the risks, and will this help us to better understand bipolar disorder? Please explain.
Which of the following is true about mixed moods? a. they are relatively rare in children with bipolar disorder b. they involve having elements of both mania and hypomania simultaneously c. they are relatively common in adults with bipolar disorder d. they can involve fluctuations from mania to depression within a single 24-hr period
Name three families of drugs used to treat depression.
Why might depression treated by cognitive-behavioral therapy be less likely to recur than depression treated by antidepressant drugs?
Which of the following is characteristic of psychoactive drugsa. They do not readily cross the blood-brain barrier.b. They alter levels of neurotransmitters.c. They can alter the amplitude of action potentials.d. They alter the speed with which action potentials travel.
What are two limitations to the monoamine theory of depression?
Which neurotransmitter is primarily associated with the pathophysiology of depression? A) Acetylcholine B) Dopamine C) Serotonin D) GABA
What kind of therapy would a professional recommend for a person going through depression and why?
Which of the following statements is true? a. GABA activity will be enhanced by tranquilizers b. Glutamate activity will be enhanced by Valium c. Prozac and other anti-depressant drugs work by decreasing serotonin c. Alcohol’s effects on behavior occur because it increases release of dopamine d. All of these are true
Clinicians have come to realize that Benzodiazepine drugs poses significant problems. Which are they?
Hypofrontality in schizophrenia means that there is: Question 3 options: a) An increased blood flow and glucose metabolism in the prefrontal cortex b) An increased blood flow and decreased glucose metabolism in the prefrontal cortex c) A decreased blood flow and increased glucose metabolism in the prefrontal cortex d) A decreased blood flow and glucose metabolism in the prefrontal cortex